Breaking News Instant updates and real-time market news.

2019-02-12 08:13:10 BRKR Bruker $35.55 0.23 (0.65%) 08:13 02/12/19 02/12 08:13 02/12/19 08:13	Bruker price target raised to $44 from $42 at BTIG BTIG analyst Sung Ji Nam raised the price target on Bruker to $44 after its Q4 results, saying the company posted solid organic revenue growth of 4.7% in FY18 and also delivered a 90bps operating margin expansion. The analyst further cites Bruker's initial 2019 guidance calling for "continued steady top line acceleration despite assumptions for more moderate end market growth and further margin expansion, driven by new product launches. Sung Ji Nam also maintains a Buy rating on Bruker.	13 Feb 28 Feb
BRKR Bruker $35.55 0.23 (0.65%) 01/02/19 NEED 01/02/19 INITIATION Target $39 NEED Strong Buy Bruker initiated with a Strong Buy at Needham Needham analyst Stephen Unger started Bruker with a Strong Buy rating and $39 price target. The analyst believes the company's increased focus on overall profit improvement can drive "significant" earnings upside. 10/09/18 UBSW 10/09/18 NO CHANGE UBSW UBS initiates coverage of Life Sciences and Diagnostics Tools sector UBS analyst Daniel Brennan initiated coverage of the Life Sciences and Diagnostics Tools sector. He said demand is accelerating across his universe but valuations are extended. He expects strong fundamentals to continue into 2019 but he said selectivity is the key. In the group, his Buy ratings include Exact Sciences (EXAS), Iqvia (IQV), NanoString (NSTG), Syneos Health (SYNH) and Thermo Fisher (TMO). 10/09/18 UBSW 10/09/18 INITIATION Target $30 UBSW Sell Bruker initiated with a Sell at UBS UBS analyst Daniel Brennan initiated Bruker with a Sell rating and $30 price target. 09/20/18 09/20/18 DOWNGRADE On The Fly: Top five analyst downgrades Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Seaspan (SSW) downgraded to Hold from Buy at Deutsche Bank with analyst Amit Mehrotra citing the recent strong performance of the shares and increased risk from the trade war between China and the U.S. 2. Bruker (BRKR) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Steve Beuchaw citing three company-specific leading indicators that he says point to a slower revenue outlook. 3. Stitch Fix (SFIX) downgraded to Neutral from Overweight at Piper Jaffray with analyst Erinn Murphy citing valuation. 4. Nutrien (NTR) downgraded to Outperform from Focus List at Scotiabank. 5. JD.com (JD) downgraded to Underperform from Outperform at CLSA with the firm lowering its price target to $29 and saying the second half will remain challenging. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

2019-02-12 08:13:10

BRKR

Bruker

$35.55: 0.23 (0.65%)

08:13

02/12/19

02/12

08:13

02/12/19

08:13

Bruker price target raised to $44 from $42 at BTIG

BTIG analyst Sung Ji Nam raised the price target on Bruker to $44 after its Q4 results, saying the company posted solid organic revenue growth of 4.7% in FY18 and also delivered a 90bps operating margin expansion. The analyst further cites Bruker's initial 2019 guidance calling for "continued steady top line acceleration despite assumptions for more moderate end market growth and further margin expansion, driven by new product launches. Sung Ji Nam also maintains a Buy rating on Bruker.

13
Feb
28
Feb

BRKR Bruker

$35.55: 0.23 (0.65%)

01/02/19: NEED

10/09/18: UBSW

10/09/18: UBSW

09/20/18

TODAY'S FREE FLY STORIES

CHRA Charah Solutions $6.80 0.005 (0.07%) 07:38 02/22/19 02/22 07:38 02/22/19 07:38 Downgrade	Charah Solutions rating change » Charah Solutions… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CONE CyrusOne 07:38 02/22/19 02/22 07:38 02/22/19 07:38 Downgrade	CyrusOne rating change » Jefferies downgrades… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Mar 18 Jun
ARAY Accuray $5.26 0.09 (1.74%) 07:38 02/22/19 02/22 07:38 02/22/19 07:38 Hot Stocks	Accuray reports results from SBRT trial » Accuray announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
C Citi $64.31 -0.35 (-0.54%) 07:36 02/22/19 02/22 07:36 02/22/19 07:36 Upgrade	Citi rating change » Jefferies sees positive… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb 15 Apr 28 May 13 Jul
BCLI BrainStorm $3.88 0.01 (0.26%) 07:35 02/22/19 02/22 07:35 02/22/19 07:35 Hot Stocks	BrainStorm announces first U.S.clinical site for Phase 2 MS study » BrainStorm announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

WPC W.P. Carey $74.39 0.25 (0.34%) 07:35 02/22/19 02/22 07:35 02/22/19 07:35 Earnings	Breaking Earnings news story on W.P. Carey » W.P. Carey sees FY19 AFFO… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
KEYS Keysight Technologies $81.74 0.67 (0.83%) 07:35 02/22/19 02/22 07:35 02/22/19 07:35 Recommendations	Keysight Technologies analyst commentary » Keysight Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb
WFT Weatherford $0.78 -0.0436 (-5.32%) , KR Kroger $28.55 -0.2 (-0.70%) … 07:35 02/22/19 02/22 07:35 02/22/19 07:35 Options	Unusual call flow in option market yesterday » Notable call activity was… WFT Weatherford $0.78 -0.0436 (-5.32%) KR Kroger $28.55 -0.2 (-0.70%) I Intelsat $24.59 0.5 (2.08%) BSX Boston Scientific $40.12 -0.01 (-0.02%) OAS Oasis Petroleum $6.07 -0.28 (-4.41%) MNST Monster Beverage $58.87 0.16 (0.27%) LKQ LKQ Corp. $27.33 0.36 (1.33%) DK Delek US $36.18 -0.8953 (-2.41%) AGI Alamos Gold $4.82 -0.055 (-1.13%) APEI American Public Education $32.93 0.88 (2.75%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 25 Feb 27 Feb 27 Feb 27 Feb 03 Mar 04 Mar 06 Mar 11 Mar 12 Mar 28 Mar 18 May 22 May 28 May
07:35 02/22/19 02/22 07:35 02/22/19 07:35 General news	Treasury Market Outlook: yields are lower in the U.S. and Europe » Treasury Market Outlook:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
WPC W.P. Carey $74.39 0.25 (0.34%) 07:34 02/22/19 02/22 07:34 02/22/19 07:34 Earnings	W.P. Carey reports Q4 AFFO $1.33, consensus $1.33 » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb

BXG Bluegreen Vacations $13.92 -0.12 (-0.85%) 07:34 02/22/19 02/22 07:34 02/22/19 07:34 Earnings	Bluegreen Vacations reports Q4 EPS 27c, consensus 24c » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
TEF Telefonica $8.85 0.12 (1.37%) 07:33 02/22/19 02/22 07:33 02/22/19 07:33 Hot Stocks	EU says Telefonica breached commitment in E-Plus acquisition » The European Commission… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb
CONE CyrusOne $52.44 -4.75 (-8.31%) 07:33 02/22/19 02/22 07:33 02/22/19 07:33 Recommendations	CyrusOne analyst commentary » CyrusOne price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Mar 18 Jun
BIIB Biogen $320.99 -14.02 (-4.18%) 07:33 02/22/19 02/22 07:33 02/22/19 07:33 Downgrade	Biogen rating change » Biogen downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 28 May
INSM Insmed $25.57 -0.42 (-1.62%) 07:33 02/22/19 02/22 07:33 02/22/19 07:33 Hot Stocks	Insmed sees FY19 ARIKAYCE revenues $80M-$90M » Insmed expects cash-based… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb

OPNT Opiant Pharmaceuticals $14.65 -0.25 (-1.68%) 07:32 02/22/19 02/22 07:32 02/22/19 07:32 Recommendations	Opiant Pharmaceuticals analyst commentary » Opiant… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
REGN Regeneron $418.66 -3.9 (-0.92%) 07:32 02/22/19 02/22 07:32 02/22/19 07:32 Downgrade	Regeneron rating change » Regeneron downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb 11 Mar 11 Mar 28 Apr 13 May
INSM Insmed $25.57 -0.42 (-1.62%) 07:31 02/22/19 02/22 07:31 02/22/19 07:31 Earnings	Insmed reports Q4 EPS ($1.19), consensus ($1.06) » Reports Q4 revenue $9.8M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
SHW Sherwin-Williams $438.49 0.56 (0.13%) 07:31 02/22/19 02/22 07:31 02/22/19 07:31 Recommendations	Sherwin-Williams analyst commentary » Sherwin-Williams price… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ZGNX Zogenix $47.88 0.35 (0.74%) 07:30 02/22/19 02/22 07:30 02/22/19 07:30 Initiation	Zogenix initiated » Zogenix initiated with a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

GE General Electric $10.03 -0.07 (-0.69%) , JNJ Johnson & Johnson $135.40 -0.91 (-0.67%) … 07:30 02/22/19 02/22 07:30 02/22/19 07:30 Options	Unusual put flow in option market yesterday » Notable put activity was… GE General Electric $10.03 -0.07 (-0.69%) JNJ Johnson & Johnson $135.40 -0.91 (-0.67%) M Macy's $24.44 -0.58 (-2.32%) CZR Caesars $9.42 -0.21 (-2.18%) KEM Kemet $18.87 -0.56 (-2.88%) COUP Coupa Software $92.20 -1.55 (-1.65%) SM SM Energy $17.01 -2.69 (-13.65%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 25 Feb 26 Feb 27 Feb 03 Mar 06 Mar 11 Mar 12 Mar 12 Mar
ROKU Roku $51.47 -2.16 (-4.03%) 07:29 02/22/19 02/22 07:29 02/22/19 07:29 Recommendations	Roku analyst commentary » Roku price target raised… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SM SM Energy $17.01 -2.69 (-13.65%) 07:29 02/22/19 02/22 07:29 02/22/19 07:29 Recommendations	SM Energy analyst commentary » SM Energy price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MRK Merck $79.82 0.38 (0.48%) 07:28 02/22/19 02/22 07:28 02/22/19 07:28 Initiation	Merck initiated » Merck initiated with an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Apr 18 May 17 Jun
SAGE Sage Therapeutics $146.14 -1.32 (-0.90%) 07:28 02/22/19 02/22 07:28 02/22/19 07:28 Initiation	Sage Therapeutics initiated » Sage Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 19 Mar

Events

Earnings calls, analyst events, roadshows and more

JRVR
Today at 08:00

James River Group - JRVR Conference Calls
W
Today at 08:00

Wayfair - W Conference Calls
BXG
Today at 08:00

Bluegreen Vacations - BXG Conference Calls
KL
Today at 08:00

Kirkland Lake Gold - KL Conference Calls
GLPG
Today at 08:00

Galapagos NV - GLPG Conference Calls
ELGX
Today at 08:00

Endologix Inc. Firm Sponsored Meetings

2 Musick, Irvine, CA
CNK
Today at 08:30

Cinemark - CNK Conference Calls
CLPS
Today at 08:30

CLPS - CLPS Conference Calls
B
Today at 08:30

Barnes Group - B Conference Calls
MNTA
Today at 08:30

Momenta - MNTA Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	AI X AI Arlington Asset Investment Spot Secondary Managers: Morgan Stanley & JMP Securities Priced at: $8.33 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARR X ARR ARMOUR Residential Spot Secondary Managers: Morgan Stanley & Barclays, Citi, Credit Suisse, Goldman Sachs & JPMorgan Priced at: $20.33 7.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CPT X CPT Camden Property Spot Secondary Managers: BofA/Merrill & Deutsche Bank Priced at: $97.85 3.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Spot Secondary Managers: Morgan Stanley, Credit Suisse & JPMorgan Priced at: $16.50 40.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OVID X OVID Ovid Therapeutics Spot Secondary Managers: Cowen & William Blair Priced at: $2.00 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SNNA X SNNA Sienna Biopharmaceuticals Spot Secondary Managers: Cowen & BMO Capital Priced at: $2.50 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	RWLK X RWLK ReWalk Robotics Spot Secondary Managers: H.C. Wainwright Priced at: $.23 19M Shares
Thurs	ACAM X ACAM Acamar Partners IPO Managers: Goldman Sachs & Deutsche Bank Priced at: $10.00 30M Shares
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	TRIL X TRIL Trillium Therapeutics Spot Secondary Managers: Cowen $1.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Bruker price target raised to $44 from $42 at BTIG

TODAY'S FREE FLY STORIES

Get Full Fly Access